INTEST CORP

During the second quarter ended June 30, 2025, none of the Company's directors or officers (as defined in Section 16 of the Securities Exchange Act of 1934)adopted orterminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K of the Securities Exchange Act of 1934.

As further discussed in “Note (10) Debt,” on August 5, 2025, we entered into the Sixth Amendment to the Loan Agreement (the “Sixth Amendment”). Pursuant to the Sixth Amendment our compliance with the Fixed Charge Coverage Ratio (as described in Section 13.2 of the Loan Agreement) is suspended for the periods ending June 30, 2025 through March 31, 2026 (the “Deferment Period”). During the Deferment Period and pursuant to the Sixth Amendment all advances under the Revolving Facility will be made only at M&T’s sole and reasonable discretion. Further, in connection with the Sixth Amendment, we have entered into a Pledge and Assignment of Cash Collateral Account Agreement (the “CCA Agreement”) pursuant to which we have pledged and granted M&T a lien on and a security interest in certain assets, as described in the CCA Agreement, through the expiration of the Deferment Period.

• 52 -

The foregoing descriptions of the July Amendment and CCA Agreement are summaries only and are qualified in all respects by the provisions of the July Amendment and CCA Agreement, copies of which are attached hereto as Exhibit 10.1 and 10.2, respectively.